Silver Oak Securities »

Sab Biotherapeutics shares owned by Silver Oak Securities

Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by Silver Oak Securities from 13F filings

Historical chart of Silver Oak Securities investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by Silver Oak Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by Silver Oak Securities

Quarter filed Position value Share count Share price at filing
2025-03-31 $30k 20k 1.48

More positions owned by Silver Oak Securities

First Tr Exchange-traded Cap Strength Etf (FTCS)
Victory Portfolios Ii Vcshs Us Eq Incm (CDC)
Apple (AAPL)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
NVIDIA Corporation (NVDA)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Series Trust Prtflo S&p500 Vl (SPYV)
First Tr Exchange-traded A Com Shs (FEX)
First Tr Exchange Traded Risng Divd Achiv (RDVY)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Vaneck Merk Gold Etf Gold Shs (OUNZ)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)

View all positions for Silver Oak Securities

Top funds holding Sab Biotherapeutics

Vivo Capital
RA Capital Management
Commodore Capital
Woodline Partners
Sessa Capital IM
BVF
Sphera Funds Management
Vanguard Group
HB Wealth Management
AWM Investment Company
Geode Capital Management
Renaissance Technologies
Pathstone Holdings
Virtu Financial
Kovitz Investment Group Partners

View all funds holding Sab Biotherapeutics